# Will an H5 virus receive an "emergence" risk rating categorized as "high" by the US CDC Influenza Risk Assessment Tool before January 1, 2026? (QID: 38922)

- Type: binary

- URL: https://www.metaculus.com/questions/38922/

- Classifier: health | strategic=False (score=0.00)

### SeenGuard

- enabled=True | lock_status=acquired

- run_filter: before=1 | skipped=0 | after=1

- debug_note=lock acquired

## Research (summary)

CALIBRATION GUIDANCE (auto-generated weekly):
BINARY CALIBRATION
- No resolved binary questions (with pre-resolution forecasts) yet.
- Advice: keep using base rates + small evidence-weighted updates; avoid big swings.

MULTIPLE-CHOICE CALIBRATION (Top-1)
- No resolved MCQ questions (with pre-resolution forecasts) yet.

NUMERIC CALIBRATION (PIT-lite + CRPS)
- No resolved numeric questions (with pre-resolution forecasts) yet.
- When numeric results exist, we’ll check p10/p50/p90 coverage and CRPS.

General takeaway: apply **small** nudges only where gaps are consistent with decent sample sizes (≥10).
— end calibration —

### Reference class & base rates
- **All IRAT Assessments:** Since its inception, the CDC has published IRAT scores for dozens of novel influenza A viruses. Of all viruses assessed to date, none have received an emergence score of 8.0 or higher. The highest published score was 7.5 for a Eurasian avian-like swine H1N1 virus in 2020. **Base rate: 0%**. This class is broad but establishes that the "high" risk threshold is a very high bar that has never been met.
- **H5 Virus IRAT Assessments:** The CDC has specifically assessed numerous H5 viruses over the years. None have ever been rated "high" for emergence. The most recent assessment of the H5N1 clade 2.3.4.4b virus involved in the US cattle outbreak yielded a moderate score of 5.79. **Base rate: 0%**. This class is more specific and shows that even concerning H5 viruses have historically remained in the moderate range.
- **IRAT Assessments During Major Zoonotic Events:** The current H5N1 panzootic and its spillover into cattle is a significant zoonotic event prompting new assessments. In this context, the A/Texas/37/2024 virus scored 5.79. The provided (hypothetical) sources state that two additional H5N1 viruses from human cases will also be assessed as "moderate" in May 2025. This gives us a reference class of three assessments during this specific event, all of which are "moderate". **Base rate: 0%**.

### Recent developments (timeline bullets)
- **2024-06-26** A/Texas/37/2024 IRAT report published — **↓** — The first H5N1 virus from the US cattle outbreak was assessed as "moderate" (5.79), establishing a benchmark below the "high" threshold.
- **2024-09-25** CDC report notes 14 H5 human detections in the 2023-24 season — **↑** — Indicates persistent, albeit sporadic, spillover pressure from animals to humans, increasing the opportunities for viral adaptation.
- **2025-05-02** (Hypothetical) IRAT for two new H5N1 human-case viruses published — **↓↓** — This is the most significant piece of evidence. It indicates that as of mid-2025, even with additional human cases, the virus's characteristics have not evolved sufficiently to push it into the "high" risk category.
- **2025-05-03** (Hypothetical) CDC news release confirms "moderate" risk — **↓** — Reinforces the May 2nd assessment, suggesting no immediate re-evaluation or disagreement among experts that would point towards a higher score.

### Mechanisms & drivers (causal levers)
- **Viral Evolution (Mutation/Reassortment):** A virus acquiring key mutations (e.g., PB2 E627K) that enhance human receptor binding (to α-2,6 sialic acids) and/or improve replication in human cells is the primary driver. A reassortment event with a human influenza virus would be a game-changer. **Impact: Large**.
- **Sustained Mammal-to-Mammal Transmission:** The current spread in cattle provides a laboratory for adaptation. Evidence of efficient transmission between mammals (especially in experimental models like ferrets) or, critically, a confirmed cluster of human-to-human transmission, would drastically increase the IRAT score. **Impact: Large**.
- **Geographic and Host Range Expansion:** Spread of the adapted virus to new mammal populations (e.g., swine, which are effective mixing vessels) or wider geographic areas increases the probability of further dangerous evolution and human exposure. **Impact: Moderate**.
- **CDC Assessment Trigger & Timeline:** A "high" score can only be assigned if the CDC convenes the IRAT panel and publishes the result. A significant event (like a human cluster) would trigger this, but the process takes time. A dangerous evolution late in 2025 might not be assessed before the deadline. **Impact: Moderate**.

### Differences vs. the base rate (what’s unusual now)
- **Novel Mammalian Reservoir:** Unlike past avian flu threats which were largely confined to birds with sporadic spillover, H5N1 has established an unprecedented reservoir in a widespread domestic mammal (dairy cattle), fundamentally changing the exposure landscape for humans.
- **Increased "At-Bats" for the Virus:** The sheer scale of the global panzootic in birds, combined with the cattle reservoir, provides vastly more opportunities for the virus to mutate and adapt to mammals than in any previous H5N1 epizootic.
- **Constraining Future Evidence:** The provided hypothetical sources for May 2025 are a major difference. We have strong, albeit hypothetical, information that the risk profile remains "moderate" well into the forecast period, which is not typical for forecasting questions.
- **Heightened Surveillance:** Global and national public health agencies are on high alert, meaning any concerning developments (genetic changes, human clusters) are more likely to be detected and trigger an IRAT assessment than they might have been in the past.

### Bayesian update sketch (for the statistician)
- **Prior:** Start with a very low prior, informed by the historical base rate of 0% across dozens of assessments. A Beta(1, 40) distribution, implying a mean probability of ~2.5%, seems appropriate, reflecting the belief that a "high" score is possible but has never occurred.
- **Evidence mapping:**
    - **(↑) Large-scale mammal adaptation (cattle outbreak):** This is a structural break from the past, increasing the chances of further evolution. **Update: Moderate ↑**.
    - **(↑) Continued sporadic human cases:** Confirms the virus can infect humans and provides ongoing material for assessment. **Update: Small ↑**.
    - **(↓↓) Hypothetical May 2025 IRAT results:** This is direct, powerful evidence that the virus has *not* crossed the threshold by mid-2025, despite the concerning context. This significantly shortens the effective timeline for a major change to occur and be assessed. **Update: Large ↓**.
- **Net effect:** The very strong negative update from the May 2025 evidence should overwhelm the positive updates from the general epidemiological situation. The posterior probability should be significantly lower than the prior.

### Indicators to watch (leading signals; next weeks/months)
- **UP indicators:**
    - **Genetic:** Publicly reported sequences of H5N1 from human or cattle isolates showing key adaptive mutations (e.g., PB2-E627K, changes in HA receptor binding domain).
    - **Epidemiological:** Report of a suspected human-to-human transmission cluster (e.g., within a family or among farm workers).
    - **Host-related:** Confirmed, widespread H5N1 outbreaks in swine populations, especially in North America.
    - **Official Communications:** CDC statements expressing a marked increase in concern or announcements of an emergency IRAT assessment outside of a normal schedule.
- **DOWN indicators:**
    - **Genetic:** Continued genetic stability in H5N1 sequences from cattle and human isolates through late 2025.
    - **Epidemiological:** A significant decline in the rate of new cattle herds being infected or a drop-off in sporadic human cases.
    - **Research:** New ferret studies on the latest H5N1 isolates showing continued inefficient transmission.
    - **Official Communications:** CDC reports after May 2025 that continue to characterize the risk as "moderate".

### Caveats & pitfalls
- **Hypothetical Source Dominance:** This forecast is heavily dependent on the provided future-dated sources for May 2025. If that information were absent, the probability would be considerably higher. The analysis assumes these sources are 100% reliable for the scenario.
- **Black Swan Event:** A rapid, major evolutionary event like a reassortment with a human flu virus could occur, invalidating the status quo suggested by the May 2025 data. The timeline for this to happen and be assessed before Jan 1, 2026 is short (~8 months), but it is not zero.
- **Definitional Rigidity:** The question resolves *only* on the publication of a score ≥8.0. A virus could become extremely dangerous in December 2025, but if the IRAT report is not published until January 2026, the question resolves "No".
- **Subjectivity of IRAT:** The IRAT score is an expert consensus, not a purely objective calculation. A shift in the panel's risk perception or methodology, while unlikely, could alter the score for a given virus.

**Final Research Summary:**
The historical base rate for any virus receiving a "high" emergence risk score is zero. While the current H5N1 situation with its spread in cattle is unprecedentedly risky, strong hypothetical evidence indicates that even with new human cases, the CDC's assessment will remain "moderate" as of May 2025, leaving a very narrow 8-month window for the dramatic viral evolution required to cross this high threshold.

Market snapshot debug:
- Metaculus: no open binary results in response
- Manifold: no open binary results in response

### Sources
- CDC Announces Plans For IRAT Assessment of Texas H5N1 Virus (afludiary.blogspot.com) — https://afludiary.blogspot.com/2024/05/cdc-announces-plans-for-irat.html
- Results of Influenza Risk Assessment Tool (www.cdc.gov) — https://www.cdc.gov/flu/pandemic-resources/irat/images/h5n1-virus-irat-report-summary-05022025.html
- Influenza Risk Assessment Tool (IRAT) Virus Report (www.cdc.gov) — https://www.cdc.gov/flu/pdf/pandemic-resources/irat/H5N1-Clade-2.3.4.4b-IRAT-Report-Summary-2024.pdf
- Influenza Risk Assessment Tool (IRAT) Virus Descriptions and Report Summaries-H5N1 (www.flu.gov) — https://www.flu.gov/news-office/uscdc/influenza-risk-assessment-tool-irat-virus-descriptions-and-report-summaries-h5n1
- Influenza Activity in the United States during the 2023–2024 Season and Composition of the 2024–2025 Influenza Vaccine (www.cdc.gov) — https://www.cdc.gov/flu/spotlights/2024-2025/2023-2024-season-summary.htm

### Research (debug)

- source=GoogleGrounding | llm=google/gemini-2.5-pro | cached=0 | n_raw=12 | n_kept=5 | cost=$0.024299

- query: emergence; high; format; metac_closes_in_period; info; post_id; question_id; US CDC Influenza Risk Assessment Tool; The Influenza Risk Assessment Tool; The IRAT; H1N1 Virus Report; H5N1 IRAT; Virus Report; Disease Controls; Influenza Risk Assessment Tool; 2024; 2020; 2026; 2016

### GTMC1 (debug)

- strategic_class=False | strategic_score=0.00 | source=llm

- gtmc1_active=False | qtype=binary | t_ms=0

- actors_parsed=0

- exceedance_ge_50=None | coalition_rate=None | median=None | dispersion=None

### Ensemble (model outputs)

- OpenRouter-Default: ok=True t_ms=10278 p=0.0100

- Claude-3.7-Sonnet (OR): ok=True t_ms=28506 p=0.0200

- Gemini: ok=True t_ms=54659 p=0.0200

- Grok: ok=False t_ms=272



### Per-model (raw + usage/cost)

#### OpenRouter-Default

- ok=True | t_ms=10278 | tokens: prompt=3807, completion=524, total=4331 | cost=$0.014757

```md

To forecast the probability of an H5 virus receiving a "high" emergence risk rating by the US CDC IRAT before January 1, 2026, we will follow the Bayesian reasoning steps outlined.

1. **Base Rate (Prior) Selection**
   - The base rate for any virus receiving a "high" emergence risk score (≥8.0) is 0%, as no virus has ever received such a score. This is based on historical data from the CDC's IRAT assessments. Therefore, the initial prior probability is effectively 0%.

2. **Comparison to Base Case**
   - Similarities: The current situation involves an H5 virus, which has historically been assessed but never rated "high" for emergence.
   - Differences: The current H5N1 panzootic involves a novel mammalian reservoir (cattle), increasing opportunities for viral adaptation. However, hypothetical evidence suggests that even with new human cases, the risk remains "moderate" as of mid-2025.

3. **Evidence Evaluation (Likelihoods)**
   - **Large-scale mammal adaptation (cattle outbreak):** Increases the probability slightly due to increased opportunities for adaptation. Likelihood ratio > 1.
   - **Continued sporadic human cases:** Slightly increases the probability as it confirms the virus can infect humans. Likelihood ratio > 1.
   - **Hypothetical May 2025 IRAT results:** Strong evidence that the virus has not crossed the threshold by mid-2025, significantly decreasing the probability. Likelihood ratio < 1.

4. **Bayesian Updating (Posterior Probability)**
   - Prior odds are effectively 0 due to the historical base rate.
   - The strong negative update from the May 2025 evidence (likelihood ratio < 1) overwhelms the positive updates from the epidemiological situation.
   - Posterior probability remains very low, significantly lower than the prior.

5. **Red Team Thinking**
   - Consideration of a black swan event, such as a rapid evolutionary change, is important but unlikely within the short timeframe remaining.
   - The hypothetical May 2025 evidence is assumed to be reliable, but if it were incorrect, the probability would be higher.
   - The resolution depends on the publication of a score ≥8.0, not just the virus becoming dangerous.

6. **Final Forecast**
   - Given the strong evidence against a "high" score by mid-2025 and the historical base rate of 0%, the probability remains very low.
   - Final: 1%

```

#### Claude-3.7-Sonnet (OR)

- ok=True | t_ms=28506 | tokens: prompt=4288, completion=1590, total=5878 | cost=$0.036714

```md

# Probability Analysis: H5 Virus Receiving "High" Emergence Risk Rating by CDC IRAT

## 1. Base Rate (Prior) Selection

For this question, I need to determine the probability that an H5 virus will receive a "high" emergence risk rating (≥8.0) from the CDC IRAT before January 1, 2026.

Looking at historical data:
- No virus of any type has ever received a "high" emergence risk rating (≥8.0) from the CDC IRAT
- The highest score ever recorded was 7.5 for an H1N1 virus in 2020
- H5 viruses specifically have never received a "high" rating
- The most recent H5N1 assessment (A/Texas/37/2024) scored 5.79 (moderate)

Given this historical context, I'll use a very low base rate. Since no virus has ever crossed the 8.0 threshold in the IRAT's history, a reasonable prior would be around 2-3%.

**Prior probability: 3%**

## 2. Comparison to Base Case

**Similarities to base case:**
- The IRAT assessment methodology remains consistent
- The threshold for "high" risk (≥8.0) is unchanged
- H5 viruses have historically scored in the "moderate" range

**Differences from base case:**
- The current H5N1 situation involves unprecedented spread in cattle, creating a novel mammalian reservoir
- This provides more opportunities for the virus to adapt to mammals and potentially humans
- The scale of the global H5N1 panzootic is larger than previous outbreaks
- Heightened surveillance means any concerning developments are more likely to be detected

These differences suggest an increased risk compared to historical patterns, but the question is whether it's enough to cross the 8.0 threshold.

## 3. Evidence Evaluation

**Evidence 1: Current H5N1 (A/Texas/37/2024) scored 5.79**
- P(E|H): If an H5 virus will receive a "high" rating, we would expect current scores to be approaching the threshold. 5.79 is still well below 8.0.
- P(E|~H): If no H5 virus will receive a "high" rating, we would expect scores to remain in the moderate range, which 5.79 is.
- Likelihood ratio: P(E|~H) > P(E|H), suggesting this evidence decreases the probability.

**Evidence 2: Hypothetical May 2025 IRAT assessments remain "moderate"**
- P(E|H): If an H5 virus will receive a "high" rating before 2026, it would be unlikely for assessments as late as May 2025 to still be "moderate."
- P(E|~H): If no H5 virus will receive a "high" rating, we would expect continued "moderate" assessments throughout 2025.
- Likelihood ratio: P(E|~H) >> P(E|H), strongly decreasing the probability.

**Evidence 3: Unprecedented mammalian adaptation in cattle**
- P(E|H): If an H5 virus will receive a "high" rating, we would expect to see novel mammalian adaptation, which we are seeing.
- P(E|~H): If no H5 virus will receive a "high" rating, we might still see concerning but not threshold-crossing adaptation.
- Likelihood ratio: P(E|H) > P(E|~H), modestly increasing the probability.

**Evidence 4: Continued sporadic human cases (14 in 2023-24 season)**
- P(E|H): If an H5 virus will receive a "high" rating, we would expect to see human cases providing opportunities for adaptation.
- P(E|~H): If no H5 virus will receive a "high" rating, we might still see sporadic cases without sustained human transmission.
- Likelihood ratio: P(E|H) slightly > P(E|~H), slightly increasing the probability.

## 4. Bayesian Updating

Starting with the prior of 3% (odds of 3:97 or about 1:32):

**Update for Evidence 2 (May 2025 assessments remain "moderate"):**
This is the strongest piece of evidence. If assessments in May 2025 still show "moderate" risk, this leaves only ~7 months for:
1. The virus to evolve significantly
2. The CDC to detect this evolution
3. An IRAT assessment to be conducted
4. The assessment to be published with a score ≥8.0

This is a very narrow window. I estimate this reduces the odds by a factor of at least 5.
New odds: 1:32 × 1:5 = 1:160
New probability: 1/(1+160) ≈ 0.6%

**Update for Evidence 3 (mammalian adaptation):**
This increases the odds by perhaps a factor of 2.
New odds: 1:160 × 2:1 = 1:80
New probability: 1/(1+80) ≈ 1.2%

**Update for Evidence 1 and 4 (current score and human cases):**
These have smaller effects that roughly balance each other out.

**Posterior probability: ~1.2%**

## 5. Red Team Thinking

**Potential blind spots:**
- I may be overweighting the hypothetical May 2025 evidence. If these sources are less reliable than assumed, the probability would be higher.
- I might be underestimating the potential for rapid viral evolution. A reassortment event with a human influenza virus could cause a sudden jump in risk.
- The IRAT scoring is somewhat subjective. A shift in expert perception of risk could lead to higher scores even without dramatic viral changes.

**Alternative scenarios:**
- A cluster of human-to-human transmission cases could trigger an emergency IRAT assessment with a higher score.
- The virus could spread to swine populations, creating a more dangerous mixing vessel scenario.
- The CDC might revise its IRAT methodology in response to the unprecedented situation, potentially leading to higher scores.

**Adjustments:**
Given these considerations, I should slightly increase my estimate to account for these tail risks. However, the May 2025 evidence still strongly constrains the probability.

## 6. Final Forecast

After considering the historical base rate, the specific evidence related to the current H5N1 situation, and potential blind spots, I arrive at a final probability of 2%.

The strongest factor limiting this probability is the hypothetical evidence that even in May 2025, H5N1 viruses will still be assessed as "moderate" risk, leaving a very narrow window for the dramatic evolution needed to cross the high-risk threshold.

Final: 2%

```

#### Gemini

- ok=True | t_ms=54659 | tokens: prompt=4103, completion=1833, total=10433 | cost=$0.023459

```md

Here is a step-by-step probabilistic forecast based on the provided information.

### 1. Base Rate (Prior) Selection

*   **Reference Class:** The most appropriate reference class is all prior emergence risk assessments conducted by the CDC using the Influenza Risk Assessment Tool (IRAT).
*   **Reasoning:** The IRAT has been in use for over a decade, and the CDC has published scores for dozens of novel influenza A viruses. This historical data provides a strong indication of how high the bar is for a virus to be categorized as "high" risk.
*   **Data:** According to the provided background and research report, out of all viruses assessed to date, **zero** have received an emergence score of 8.0 or higher. The highest score ever published was 7.5.
*   **Prior Probability:** A raw base rate would be 0%, but this implies impossibility. A more reasonable prior can be established using a Laplace-style estimator to account for the possibility of an event that has not yet occurred. Assuming roughly 40 past assessments (a conservative estimate for "dozens"), the prior probability would be approximately (0+1)/(40+2) = 1/42, which is about 2.4%. I will set the initial prior at **P(H) = 3%**. This reflects that a "high" rating is a rare event that has never happened but is not impossible. In odds form, this is 3:97, or approximately 1:32.

### 2. Comparison to Base Case

*   **Similarities:** The current situation involves the assessment of a novel H5 avian influenza virus that has spilled over from animals, which is the standard scenario for an IRAT assessment. The methodology and scoring criteria remain the same.
*   **Differences:** The primary and most significant difference is that the H5N1 clade 2.3.4.4b virus has established a large, sustained reservoir in a mammalian species (dairy cattle). This is unprecedented for H5 viruses and fundamentally changes the risk landscape. It dramatically increases the opportunities for the virus to adapt to mammals and increases human exposure, making the current situation far more concerning than the historical base case of sporadic avian-to-human spillovers. This key difference suggests the probability should be higher than the historical base rate alone would imply.

### 3. Evidence Evaluation (Likelihoods)

I will update the prior based on the key pieces of evidence provided.

*   **Evidence 1: The unprecedented H5N1 outbreak in US dairy cattle (ongoing since early 2024).**
    *   **P(E | H):** If a "high" risk H5 virus were to emerge, it would very likely be preceded by a period of sustained transmission and adaptation in a mammalian population. This evidence is highly consistent with a pathway to a "Yes" outcome.
    *   **P(E | ~H):** It is also possible for the virus to circulate in cattle for years without acquiring the specific mutations needed for efficient human-to-human spread. However, the scale of this outbreak makes the situation much more dangerous than the baseline.
    *   **Likelihood Ratio:** The ratio P(E | H) / P(E | ~H) is significantly greater than 1. This evidence strongly **increases** the probability from the initial prior. Updating the prior odds of 1:32 with a moderate likelihood ratio (e.g., 3) would bring the odds to 3:32, or a probability of about 8.6%.

*   **Evidence 2: Hypothetical IRAT results from May 2025 for two new human-case viruses are published as "moderate".**
    *   **P(E | H):** If a virus were to be rated "high" before January 2026, it is very *unlikely* that other contemporary isolates from human cases would still be rated "moderate" as late as May 2025. This would imply an extremely rapid and significant evolutionary jump occurred only in the final 7-8 months of the resolution period.
    *   **P(E | ~H):** If no virus is rated "high," it is extremely *likely* that all interim assessments would remain in the "moderate" range. This evidence is highly consistent with a "No" outcome.
    *   **Likelihood Ratio:** The ratio P(E | H) / P(E | ~H) is much less than 1. This is very strong evidence that **decreases** the probability.

### 4. Bayesian Updating (Posterior Probability)

Let's perform the update using the probability from Evidence 1 (8.6%, or odds of ~1:11) as our new prior.

*   **Prior Odds:** ~1:11
*   **Evidence:** May 2025 assessments are "moderate".
*   **Likelihood Ratio Estimation:** Let's estimate the probability of seeing this evidence under both hypotheses. P(May assessments are moderate | High score by Jan 2026) might be 15%. P(May assessments are moderate | No high score by Jan 2026) might be 95%. The likelihood ratio is 0.15 / 0.95 ≈ 1/6.3.
*   **Posterior Odds:** Prior Odds × Likelihood Ratio = (1/11) × (1/6.3) ≈ 1/69.
*   **Posterior Probability:** 1 / (1 + 69) = 1/70 ≈ 1.4%.

*   **Final Piece of Evidence: The Current Date.** The prompt specifies the current date is **October 13, 2025**. This leaves only ~2.5 months until the deadline. The process of detecting a dangerous new variant, isolating it, conducting lab studies (e.g., in ferrets), convening the IRAT expert panel, and publishing the final report takes considerable time (typically several months). For a "high" score to be published by December 31, 2025, the triggering event (e.g., a cluster of human-to-human transmission) would almost certainly have to have occurred already. Since no such event has been publicly reported, the remaining time window is a very powerful constraint. This final piece of evidence further **decreases** the probability. The odds of 1:69 should be reduced further.

### 5. Red Team Thinking

*   **Main Argument for a Higher Probability:** The primary risk is a "black swan" event, specifically a reassortment between H5N1 and a circulating human influenza virus. Such an event could create a new virus that is immediately dangerous. In this scenario, the CDC would likely initiate an emergency, fast-tracked IRAT assessment that could potentially be completed within the remaining ~11-week window.
*   **Plausibility:** While possible, this scenario requires a chain of low-probability events: the specific reassortment must occur, it must be detected quickly, and the entire assessment and publication process must be completed in record time.
*   **Counterargument:** The most powerful evidence remains the hypothetical May 2025 "moderate" scores and the very short time remaining. These factors indicate that the virus's evolution has been slow and that the procedural window for a "Yes" resolution is nearly closed.
*   **Adjustment:** My calculated probability of ~1.4% seems low, but the reasoning is sound. To account for the small but non-zero chance of a black swan event and an emergency assessment, I will slightly increase my final forecast from the calculated value. A 2% forecast represents a 1-in-50 chance, which feels like an appropriate weight for this high-impact, low-probability scenario within the tight deadline.

### Final Forecast

The historical base rate for a "high" emergence score is zero. While the current H5N1 situation in cattle is uniquely concerning and increases the baseline risk, strong evidence provided in the prompt indicates that the virus's risk profile remained "moderate" as of May 2025. Given the current date of October 13, 2025, the extremely short remaining time window for a major evolutionary event to occur, be detected, and have a full IRAT assessment published makes a "Yes" resolution highly unlikely. The small remaining probability is reserved for a "black swan" event like a sudden viral reassortment combined with a rapid emergency assessment by the CDC.

Final: 2%

```

#### Grok

- ok=False | t_ms=272 | tokens: prompt=0, completion=0, total=0 | cost=$0.000000

- error=HTTP 429: Your team 0101076a-72f1-4f25-a038-b346d74bbc8d has either used all available credits or reached its monthly spending limit. To continue making API requests, please purchase more credits or raise your spending limit.

### Aggregation (BMC)

- final_probability=0.0472

- bmc_summary={"mean": 0.04720360495854533, "p10": 5.7340924137437514e-08, "p50": 0.0025062065839389393, "p90": 0.1555992328590688}